Innate Pharma S.A.
Innate Pharma S.A. (IPHA) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
ipha · market cap & enterprise value · FMP · as of Jun 8, 2026
Core market cap & key metrics
As of Jun 8, 2026, Innate Pharma S.A. (IPHA) has a market cap — also referred to as its net worth or valuation — of $165,269,787, making it one of the top most valuable companies globally. Market Cap = $1.76 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Innate Pharma S.A. (IPHA) has a market cap — also referred to as its net worth or valuation — of $165,269,787 as of Jun 8, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Innate Pharma S.A. reached its all-time high market cap of $612,916,582.18 on Sep 17, 2021. Comparing the Innate Pharma S.A. market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Innate Pharma S.A. net worth vs peers and ask how Innate Pharma S.A. valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
IPHA market cap · 6 questionsInnate Pharma S.A.'s net worth — measured as market capitalization — is $165,269,787 as of Jun 8, 2026. It ranks #0 globally. Market Cap = $$1.76 (price) × shares outstanding.